NCT00020579View on ClinicalTrials.gov

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

PHASE1CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

March 31, 2001

Primary Completion Date

April 30, 2008

Study Completion Date

October 31, 2008

Conditions
Cancer
Interventions
DRUG

entinostat

Trial Locations (3)

20892

NCI - Center for Cancer Research, Bethesda

20889-5000

National Naval Medical Center, Bethesda

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

National Institutes of Health Clinical Center (CC)

NIH

NCT00020579 - MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma | Biotech Hunter | Biotech Hunter